[The inhibitor of integrins Cilengitide: a new active drug in neuro-oncology]. | Bull Cancer;98(9): 1083-90, 2011 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

[The inhibitor of integrins Cilengitide: a new active drug in neuro-oncology]. / L'inhibiteur d'intégrines Cilengitide : un nouveau principe actif en neuro-oncologie.

Leblond, Pierre; Meignan, Samuel; Le Tinier, Florence; Bethe, Ullrich; Lansiaux, Amélie.

Affiliation

Leblond P; Centre Oscar-Lambret, unité d'oncologie pédiatrique, Lille Cedex, France. p-leblond@o-lambret.fr

Bull Cancer ; 98(9): 1083-90, 2011 Oct.

Article in Fr | MEDLINE | ID: mdl-21914576

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Snake Venoms / Brain Neoplasms / Integrins / Angiogenesis Inhibitors / Molecular Targeted Therapy Limits: Animals / Humans Language: Fr Journal: Bull Cancer Year: 2011 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Snake Venoms / Brain Neoplasms / Integrins / Angiogenesis Inhibitors / Molecular Targeted Therapy Limits: Animals / Humans Language: Fr Journal: Bull Cancer Year: 2011 Document type: Article Affiliation country: Country of publication: